Abstract: Thirty-two canine mammary tubulopapillary carcinomas and 14 simple adenomas were studied by immunohistochemistry for the expression of UDP-galactose:ceramide galactosyltransferase (UGT8). The majority of tissue specimens (57%) representing adenomas had no or weak reaction with anti-UGT8 antibodies (0-2 pts according to IRS scale) in comparison to the majority of carcinomas (90%) which stained with high intensities (3-9 pts according to IRS scale). When the average values of the reaction intensities (IRS) for malignant and benign tumors were compared, using the Mann-Whitney U-test, significant differences in UGT8 expression between them were found (P < 0.001). Mammary tubulopapillary carcinomas were further analyzed by IHC and the same rabbit polyclonal antibody directed against UGT8 according to their malignancy grade. It was found that the level of UGT8 increased in tumor specimens together with their grading. A comparison of the average values of the reaction intensity (IRS scale) revealed a significant difference (Mann-Whitney U-test, P < 0.05) in UGT8 expression between tumors representing malignancy grades G3 and G1. Based on the obtained results, it is proposed that UGT8 is associated with malignancy of canine mammary gland cells and may have a potential value as a diagnostic marker.
Introduction
UDP-galactose:ceramide galactosyltransferase (UGT8, CGT, C.E. 2.4.2.62) is the enzyme involved in the synthesis of galactosylceramide (GalCer) which is the major glycosphingolipid of myelin produced by oligodendrocytes in the central nervous system and Schwann cells in the peripheral nervous system [1] [2] [3] [4] . It was suggested that GalCer is involved in myelin function and stability but not in its biogenesis [5] [6] [7] . This glycosphingolpid is also present in other organs such as the kidney, small intestine, colon, liver, and testis [8] [9] [10] [11] .
It has been shown recently that UGT8 is one of six genes which an elevated level correlates with a highly increased risk of lung metastases in breast cancer patients [12] . Also, elevated expression of UGT8 gene in breast cancer was significantly associated with negative expression of estrogen receptors www.fhc.viamedica.pl (ER-negativity), and therefore with a more malignant phenotype [13, 14] . Studies performed on the level of mRNA expression using microarray analysis and quantitative RT-PCR were further confirmed by immunohistochemistry. It has been shown that high expression of UGT8 protein is a significant index of tumor aggressiveness and a potential marker for the prognostic evaluation of lung metastases in breast cancer [15] . So far, there were no reports about the expression of UGT8 in canine mammary gland tumors, therefore, the present study was undertaken to analyses the expression of this enzyme in malignant and benign canine tumors.
Material and methods
Tissue specimens. Tissue specimens were obtained from 46 female dogs of different pure and mixed breeds, aged 7 to 15 years, undergoing surgery at the Department of Surgery, Faculty of Veterinary Medicine, University of Environmental and Life Sciences, Wroclaw, Poland. The tumors were removed with a margin of approximately 2 cm of healthy tissues.
Histopathological examination and immunohistochemical reactions (IHC).
For histological examination the tumor specimens were fixed in 10% neutral-buffer (7.0-7.4 pH) formalin and embedded in paraffin. Paraffin sections, mounted on Superfrost slides were dehydrated and stained with hematoxylin and eosin. The tumors were classified on the basis of the diagnostic criteria of the World Health Organization [16] . Malignant tumors were classified according to the Bloom-Richardson scale modified by Elston and Ellis [17] . The method for the evaluation of the malignancy grade included three parameters scored in the scale from 0 to 3 points: formation of tubules (evident, moderate, slight), polymorphism of cell nuclei (slight, moderate, marked), number of mitotic figures per 10 microscope fields at the magnification of ×400 (0-7, 8-16, ≥ 17). The sum of the points provided potential to distinguish 3 grades of malignancy (G) among the tumors: 0-5 pts. -G1 grade, 6-7 pts. -G2 grade, 8-9 pts. -G3 grade. Immunohistochemical staining was performed on 4-µm-thick paraffin sections. First, the sections were deparaffinized in xylene and gradually rehydrated using ethanol. Antigen retrieval was performed by boiling the tissue sections in Antigen Retrieval Solution (pH 9, 97°C, 20 min; Dako, Glostrup, Denmark). Endogenous peroxidase activity was blocked by 5 min. incubation with 3% H 2 O 2 . Then the sections were incubated with a primary rabbit polyclonal antibody directed against UGT8 (Atlas Prestige Antibodies, Stockholm, Sweden) diluted in Background Reducing Antibody Diluent (Dako) for 1 h at room temperature. Peroxidase conjugated goat secondary antibodies (EnVision/HRP; Dako) and diaminobenzidine tetrachloride (DAB; Dako) were used to visualize the studied antigen. All tissue sections were counter-stained with Mayer's hematoxylin. As positive control for the UGT8 IHC a previously breast cancer specimen characterized by its high expression in cancer cells was utilized, whereas Primary Negative Control (Dako) was used as the negative control [15] .
Evaluation of IHC reactions. The IHC sections were evaluated using BX-53 light microscope (Olympus, Tokyo, Japan) by two independent pathologists. The level of UGT8 expression was ranked using the modified semi-quantitative Immunoreactive Remmele Score (IRS) according to Remmele and Stegner (Table 1 ) [18] . This method takes into account both the proportion of stained cells and the intensity of the reaction, while its final results represent the product of the two parameters, with values ranging from 0 to 12 points (no reaction = 0 points, weak reaction = 1--2 points, moderate reaction = 3-4 points and intense reaction = 6-12 points).
Statistical analysis. When groups of data were compared, but failed to satisfy the assumptions of the parametric test, the Mann-Whitney U-test, the non-parametric equivalent of Student's t-test, was used. The results were considered statistically significant when P < 0.05 in both analysis. Software Statistica 7.1 (STATSoft, Cracow, Poland) was used for all analyses. 
Results
On the basis of histological examination, 32 mammary tubulopapillary carcinomas and 14 simple adenomas were included in the present study. The primary carcinomas were further classified according to the Bloom-Richardson modified by Elston and Ellis [17] as G1 (14 cases), G2 (11 cases) and G3 (7 cases). Expression of UGT8 in the paraffin sections of malignant and benign tumors was analyzed using rabbit polyclonal antibodies directed against human UGT8 ( Figure 1A and B) . The majority of tissue specimens (57%) representing adenomas had no or weak reaction with anti-UGT8 antibodies (0-2 pts according to IRS scale) in comparison to the majority of carcinomas (90%) which stained with high intensities (3-9 pts according to IRS scale). When the average values of the reaction intensities (IRS) for malignant and benign tumors were compared by the Mann-Whitney U-test, significant differences in UGT8 expression between them were found (P < 0.001, Figure 1C ). Mammary tubulopapillary carcinomas were further analyzed by IHC and the same rabbit polyclonal antibody directed against UGT8 according to their malignancy grade. It was found that the level of this antigen increased in tumor specimens together with their grading. The average values of the reaction intensity (IRS scale) were significantly different (Mann-Whitney U-test, P < 0.05) in UGT8 expression between tumors representing malignancy grades G3 and G1 (Figure 2 ).
Discussion
Based on the results obtained for human breast cancer (Dziegiel et al., 2010) , the intensities of UGT8 staining in node-positive and node-negative tumors were also compared. Node-positive cases were characterized by a higher average IRS value (5.25 ± 1.91) than nodenegative cases (4.45 ± 2.09). However, this difference was not significant (data not shown).
It has been shown recently that expression of UGT8 is highly elevated in breast cancer metastases to the lung in comparison to matched primary tumors and increased expression of this enzyme are associated with progression to a more malignant phenotype [12] [13] [14] [15] . Based on these results we studied the expression of UGT8 in canine tubulopapillary carcinomas and simple adenomas. Our results showed that canine malignant tumors had much higher expression of UGT8 in comparison to benign tumors. As in humans, an elevated expression of UGT8 correlated with progression to a more malignant phenotype. Therefore, our data show that UGT8 expression is associated with canine mammary carcinoma and could represent a potentially new marker of malignancy and tumor aggressiveness in dogs. Immunohistochemical staining of (A) simple adenoma and (B) canine mammary tubulopapillary carcinoma with anti-UGT8 rabbit polyclonal antibodies. Reaction intensities with rabbit polyclonal antibodies for UGT8 (C) were calculated on the basis of the semiquantitative IRS scale of Remmele and Stegner (1987) and are represented as means:
* P < 0001 for mammary tubulopapillary carcinomas (n =32) as compared with adenomas (n =14) (Mann -Whitney U-test) Figure 2 . UGT8 expression in canine mammary tubulopapillary carcinomas of different malignancy grades: G1 (n =14), G2 (n =11) and G3 (n =7). Reaction intensities with rabbit polyclonal antibodies for UGT8 were calculated on the basis of the semiquantitative IRS scale of Remmele and Stegner (1987) The question remains as to the biological meaning of increased expression of UGT8. This enzyme is involved in the biosynthesis of GalCer, and it is possible that in human cancer, including breast cancer, an accumulation of this glycosphingolipid in tumor cells inhibits apoptosis, which facilitates metastatic cells to survive in the hostile micro-environment of the target organ [15, 19] . Breast tumors and canine mammary neoplasia have many features in common. Both of them are age-and hormone-dependent, and are often similar in their histological appearance as well as the expression of molecular markers [20] [21] [22] [23] . Therefore we suggest that GalCer, similarly to humans, may have an antiapoptotic function in canine mammary tumors. However, this hypothesis needs further functional studies.
In summary, our data suggest that UGT8 expression is associated with degree of malignancy of canine mammary gland tumors and may be of potential value as a diagnostic marker.
